Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Aldeyra Therapeutics, Inc.”

38 pharma patents match "Aldeyra Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 38
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 38 pharmaceutical patents matching "Aldeyra Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

38 results for “Aldeyra Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 10550085

    Deuterated compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  2. US 10543181

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  3. US 10426790

    Treatment of allergic eye conditions with cyclodextrins

    Aldeyra Therapeutics, Inc. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  4. US 10414732

    Polymorphic compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  5. US 10213395

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  6. US 10202348

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted
  7. US 10111862

    Traps in the treatment of macular degeneration

    Aldeyra Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted
  8. US 9896419

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  9. US 9814701

    Compositions and methods for the treatment of macular degeneration

    Aldeyra Therapeutics, Inc. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  10. US 9687481

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  11. US 9650342

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  12. US 9604997

    Peri-carbinols

    Aldeyra Therapeutics, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  13. US 9364471

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  14. US 9265759

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted